This is a Flash movie.
This is a Flash movie.
 Advanced Search
Subscribe for China Now Newsletter
Home   >   News

  • Special Supervision & Examination on the OBOGS of Medical Institutions will be on
    State Food & Drug Administration informed on Jul 16th that special supervision and examination on onboard oxygen generating system(OBOGS) in use in medical institutions of 18 provinces (Districts and cities) including Beijing, would be on. (September 03, 2010)

  • MRI-compatible incubator increases procedure use for neonates
    MRI exams can provide valuable information about neurological abnormalities in preterm infants. But the process of having an MRI exam can be hazardous to very fragile and unstable neonates, limiting the value of this powerful technology -- unless you have an MRI-compatible incubator. (September 02, 2010)

  • New non-invasive method to diagnose osteoarthritis
    Researchers at New York University have developed an innovative way to look at the development of osteoarthritis in the knee joint-one that relies on the examination of sodium ions in cartilage. (September 01, 2010)

  • The Application Demonstration Project of Domestic Innovative Medical Devices has been initiated
    Recently, "Application Demonstration Project of Domestic Innovative Medical Devices" sponsored jointly by Ministry of Science & Technology and Ministry of Public Health has been officially initiated. (September 01, 2010)

  • MRI beats FDG-PET for early Alzheimer's detection
    MRI may be a more practical clinical biomarker for early detection of Alzheimer's disease than FDG-PET, according to a new study published in the September issue of Radiology. (August 31, 2010)

  • Surgical robots could be used for teleanesthesia: Study
    An existing surgical robot could be used to perform complex regional anesthesia procedures in theory, allowing expert anesthesiologists to perform robot-assisted procedures from remote locations. (August 31, 2010)

  • FDA clears SonoSite's LumenVu Catheter Guidance System
    SonoSite, Inc., the world leader and specialist in bedside and point-of-care ultrasound, announced recently that it received FDA clearance for its innovative LumenVu® Catheter Guidance System. (August 30, 2010)

  • Spectral Molecular Imaging completes development of SkinSpect for melanoma detection
    Cascade Technologies, Inc. announced recently that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will complete development of its new product SkinSpect™, aimed at early detection of melanoma by hyperspectral imaging. (August 30, 2010)

  • Scientists discover Magnetic Resonance Spectroscopy can rapidly diagnose degenerative disorders
    A team of American scientists claim that a new method of testing for neurological diseases could provide doctors with a rapid and non-invasively method of diagnosing degenerative disorders. (August 27, 2010)

  • CHINA-HOSPEQ2010 has come to a successful conclusion at Beijing's China National Convention Center
    CHINA-HOSPEQ2010, co-hosted by China's Ministry of Health, Chinese Hospital Association, China Association of Medical Equipment and other groups, was held in National Convention Center in Beijing on August 19-21. (August 26, 2010)

  • Pen-size plasma sterilization device
    Prof. Jiunn-Der Liao of Department of Materials Science and Engineering at National Cheng Kung University (NCKU), Tainan, Taiwan, has led Post Doctorate Chih-Chiang Weng and a research team to develop a pen-size plasma sterilization device. (August 26, 2010)

  • MRI and MR spectroscopy determine internal fat distribution: Study
    Why is it that some people lose weight and body fat when they exercise and eat less and others don't? German researchers say MRI and magnetic resonance (MR) spectroscopy can provide the answer - and help predict who will benefit from lifestyle changes. (August 26, 2010)

  • HighRes Biosolutions to install automation platform in China
    HighRes Biosolutions, the leader in laboratory automation for life sciences, announced recently that it is building a system for an undisclosed laboratory in Shanghai, China. The new system will be installed in the fall of 2010. (August 25, 2010)

  • Scientists report global shortage of radioactive isotopes for medical scans
    Twenty million medical scans and treatments are done each year that require radioactive isotopes and scientists today described a global shortage of these life-saving materials that could jeopardize patient care and drive-up health care costs. (August 24, 2010)

  • Whole body MRI may help to diagnose suspected child abuse
    Whole-body magnetic resonance imaging (MRI), which is highly accurate at detecting soft-tissue abnormalities, may serve a role in detecting suspected child abuse in infants, according to a study in the September issue of the American Journal of Roentgenology. (August 24, 2010)

  • Quantitative image analysis uncovers more living liver donors
    Quantitative image analysis may be able to significantly increase the number of living liver donors, according to research from the University of Colorado School of Medicine in Aurora. (August 23, 2010)

  • ASIR coronary CTA technique reduces radiation dose by 27%
    A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent. (August 23, 2010)

  • Researchers develop method to predict lifetime of implants
    Extra-hard coatings made from diamond-like carbon (DLC) extend the operating lifetime of tools and components. In artificial joints, however, these coatings often fail because they detach. (August 18, 2010)

  • World's smallest ultrasonic transducers came out
    Scientists and Engineers at The University of Nottingham have built the world's smallest ultrasonic transducers capable of generating and detecting ultrasound. (August 18, 2010)

  • FDG-PET before RT can modify planned NSCLC treatment
    FDG-PET scans of non-small cell lung cancer (NSCLC) patients reviewed before radiation therapy (RT) may lead to significant changes in treatment strategy and radiation therapy planning. (August 17, 2010)

  • Dual-source CT finds coronary artery disease in A-fib patients
    Dual-source CT (DSCT) accurately identifies significant coronary artery disease in patients with rate-controlled atrial fibrillation, researchers from Germany report in the July 11 online issue of European Heart Journal. (August 16, 2010)

  • Researchers to develop a prototype for laser based radiation therapy
    Currently, new treatment facilities for radiation therapy with ions are built all over the world. These particles destroy cancer cells and have a better ability to spare the surrounding healthy tissue than other techniques. (August 13, 2010)

  • New optical imaging technique holds potential to improve angioplasty
    A new optical imaging technique described in the journal Review of Scientific Instruments, which is published by the American Institute of Physics, holds the potential to greatly improve angioplasty, a surgery commonly performed to treat patients with a partially or completely blocked coronary artery that restricts blood flow to the heart. (August 12, 2010)

  • New computerized approach for dental restoration procedures
    Oral surgeons may one day have an easier, less costly approach to one important aspect of dental restoration, thanks to a newly patented process developed by researchers at Missouri University of Science and Technology (Missouri S&T). (August 12, 2010)

  • Scientists develop life long hip joint replacement device
    Total knee and hip joint replacement devices that last a lifetime are closer to reality thanks to recent breakthroughs in Department of Physics laboratories at the University of Alabama (August 11, 2010)

  • FDA clears RyMed's InVision-Plus CS needleless IV connector
    RyMed Technologies announced recently that it has received FDA 510(k) clearance for its newest IV connector, InVision-Plus® CS™ with Chlorhexidine-Silver Ion Engineering. (August 11, 2010)

  • Short, split-dose radiation helps palliate advanced NSCLC
    Short-course split-dose radiotherapy helps relieve the symptoms of advanced non-small cell lung cancer (NSCLC), Polish oncologists report. (August 10, 2010)

  • Aptus reports successful treatment with EndoStapling System in Europe
    Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced that several patients with aortic aneurysm disease have been successfully treated with the Aptus EndoStapling System in Europe. (August 10, 2010)

  • TrueBeam technology reduces cancer radiation treatment time
    The Department of Radiation Oncology at the University of Alabama at Birmingham Comprehensive Cancer Center is among the world's first to begin using radiation technology that dramatically reduces treatment times. (August 09, 2010)

  • New assist system for the operating theatre
    With the new Trimano 3D support arm, Maquet, the workflow specialists, are able to further expand their already extensive product portfolio in the field of assist systems and OR accessories. The assist system is deployed as a "third hand" for the surgeon, in orthopaedics and traumatology. (August 06, 2010)

  • Scientists develop laser probe for early detection of oral cancer
    UC Davis researchers have developed a laser probe for the early detection of oral cancer. A trial with human subjects shows that the device could also be used during surgery to locate the edges of a tumor. (August 06, 2010)

  • Accuray receives Shonin approval to market CyberKnife G4 Robotic Radiosurgery System
    Accuray Incorporated, a global leader in the field of radiosurgery, announced recently it received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the CyberKnife® G4 Robotic Radiosurgery System to treat tumors non-invasively anywhere in the body, inclusive of head and neck. (August 04, 2010)

  • RANZCR optimization training workshop enables radiation dose reduction in adult scans
    Numerous radiology practices were able to significantly reduce the radiation dose associated with multi-detector computed tomography (MDCT) scans by participating in a one day dose optimization workshop provided by the Royal Australian and New Zealand College of Radiologists (RANZCR). (August 03, 2010)

  • Functional MRI can be used to assess tumor viability
    Pancreatic ductal adenocarcinoma (the disease commonly referred to as pancreatic cancer) carries the worst prognosis of any cancer. As current treatments offer minimal benefit, entirely new approaches are needed. (August 02, 2010)

  • Microsulis launches Acculis percutaneous microwave tissue ablation system at ECIO
    Microsulis Medical Ltd (MML), the leading company in microwave technology for medical devices, has successfully launched the Acculis percutaneous microwave tissue ablation system, Accu2i pMTA, at the second European Conference on Interventional Oncology (ECIO) in Florence, Italy. (August 02, 2010)

  • Reliance on assistive devices can affect everyday life in multiple ways: Study
    Obese older adults are more likely to use walkers, canes and other mobility devices at a younger age, and may run the risk of using them incorrectly, according to new research from Purdue University. (July 30, 2010)

  • CTC is not cost effective compared with colonoscopy: Study
    A UNC physician authored an editorial in the July 27 online issue of the Journal of the National Cancer Institute (JNCI) commenting on results of an analysis of the cost effectiveness of colonoscopy versus computed tomographic colonography (CTC). (July 29, 2010)

  • Scientists develop nanoprobe to detect blood vessel growth in tumors
    Formation of new blood vessels, also known as angiogenesis, is crucial for sustained tumor growth and cancer metastasis. Recently, clinically available therapies to suppress the growth of these vessels have been available to improve patient survival in some cancer types. (July 29, 2010)

  • Methodist surgical team completes first phase training to implant new total artificial heart
    A 13-member surgical team from the Methodist DeBakey Heart & Vascular Center completed the first phase of training to implant a new total artificial heart designed to completely replace the heart's function while the patient waits for a heart transplant. (July 28, 2010)

  • Boston Scientific launches Neuroform EZ Stent System
    Boston Scientific Corporation recently announced the U.S. and European launches of the Neuroform EZ™ Stent System, its fourth-generation intracranial aneurysm stent system designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms. (July 28, 2010)

  • Glucose monitoring device helps to manage pets' diabetes
    The treatment of diabetes was revolutionized in 1922 when insulin was isolated from dogs. Since then, significant advances in human medicine have made diabetes more manageable for patients. Now, human medicine has returned the favor and used these advances to help dogs with diabetes. (July 27, 2010)

  • Analogic Medical Equipment receives ISO 13485 certification and ships first MRI amplifier product
    Analogic Corporation, a leading provider of medical imaging and aviation security technology, announced recently that the Company's newly established China operations, Analogic Medical Equipment (Shanghai) Co., Ltd., has received ISO 13485 certification and shipped its first MRI amplifier product. (July 27, 2010)

  • FDA Cautions Against Using Unapproved IUDs
    Federal health officials are warning medical practitioners around the country not to use unapproved intrauterine devices (IUDs).In a July 22 letter, FDA reminds health professionals that using unapproved IUDs raises concerns about effectiveness and safety. (July 26, 2010)

  • Where's The Doctor? Next Generation Surgical Robots
    As physician-guided robots routinely operate on patients at most major hospitals, the next generation robot could eliminate a surprising element from that scenario -- the doctor. (July 23, 2010)

  • SPECT MPI detects increased risk of sudden cardiac death
    SPECT myocardial perfusion imaging (MPI) can help determine whether patients with left ventricular ejection fraction (LVEF) measurements of greater than 35% have an increased risk of sudden cardiac death. (July 23, 2010)

  • Applied Spine Technologies receives U.S. Patent for dynamic stabilization device
    Applied Spine Technologies, Inc., a medical device company focused on motion preservation of the lumbar spine, received a Notice of Allowance on July 12, 2010 from the U.S. Patent and Trademark Office. (July 22, 2010)

  • China has developed independently the first minimally invasive surgical robot system "MicroHand A"
    The first set of China-made robot ¡°MicroHand A¡± system for the mini-invasive surgery has passed the appraisal by Tianjin Science &Technology Commission. It is the first successfully developed robot for mini-invasive surgery in China. (July 21, 2010)

  • Visage Imaging releases Amira 5.3 single platform brain imaging tool
    Visage Imaging®, Inc., a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), is pleased to announce the immediate release of Amira 5.3, a new major version of its market-leading software platform for visualizing, analyzing, and presenting complex 3D and 4D biomedical data. (July 20, 2010)

  • SuiteMed applauds HHS final rules on "meaningful use" of EHR
    SuiteMed, LLC applauds the long-awaited final rules from the US Health and Human Services Department on "Meaningful Use" of an Electronic Health Record (EHR). (July 19, 2010)

  • New microfluidic device for effective HIV diagnosis
    UC Davis biomedical engineer Prof. Alexander Revzin has developed a "lab on a chip" device for HIV testing. Revzin's microfluidic device uses antibodies to "capture" white blood cells called T cells that are affected by HIV. (July 19, 2010)

  • Concert Medical releases 'Conductor' family of Interventional Coronary Guidewires in U.S.
    Concert Medical, LLC recently announced the launch of the "Conductor™" family of Interventional Coronary Guidewires to the U.S. market. These guidewires are designed to address an extensive range of coronary disease cases at a superior value. (July 16, 2010)

  • SPECT MPI detects increased risk of sudden cardiac death
    SPECT myocardial perfusion imaging (MPI) can help determine whether patients with left ventricular ejection fraction (LVEF) measurements of greater than 35% have an increased risk of sudden cardiac death. (July 15, 2010)

  • Cardiac Science launches CareCenter MD PC-based diagnostic workstation
    Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, recently expands its ECG and cardiac stress product lines with CareCenter MD, a multimodality PC-based diagnostic workstation designed for today's physician practices. (July 14, 2010)

  • Cross-disciplinary research experts develop Responsive Epilepsy Control System
    The Brain Mind Welfare Team of National Cheng Kung University (NCKU), Tainan, Taiwan, formed by cross-disciplinary research experts from information engineering, medical information and social science, has developed a Responsive Epilepsy Control System which proved to be successful in epileptic rats. (July 13, 2010)

  • An Electronic TCM appears in the World Expo 2010 Shanghai
    Recently, in the city future house of World Expo Shanghai, there appears an electronic TCM, which could look, listen, ask, touch and prescribe just as a real doctor. However, the "doctor", which is good at diagnosis with hanging wire, is a payback for more than 30 years of unremitting efforts of several generations of experts in Shanghai University of TCM. (July 12, 2010)

  • SFDA calls for better supervision on the quality of drugs and medical devices for earthquake relief
    On April 14, 2010, a 7.1-magnitude earthquake occurred in Yushu County, Qinghai Province, causing serious loss of life and property. For the relief, the SFDA has issued a notice to call for strengthening supervision on quality of drugs, medical devices and food, especially on the donation. (July 09, 2010)

  • Minimal invasive training base in cardiovascular surgery of Ministry of Health opened in Shanghai
    Recently, a project about Thoracoscopy and composite technology in Cardiovascular Disease Research, organized by the Ministry of Health for nonprofit industry started in Beijing. In the project, Shanghai Grand mind Hospital was recognized as a seventh of minimally invasive training bases in cardiovascular surgery in China. (July 09, 2010)

  • Point-of-care ultrasound useful for fracture diagnosis
    Clinicians trained to use portable, point-of-care ultrasound equipment can achieve a high level of accuracy in identifying fractures in children and young adults when x-ray units are not available, according to a study published online in Injury. (July 08, 2010)

  • A liver cancer risk assessment system was launched by hepatic experts in Guangdong
    Recently, hepatic experts in Guangdong launched a liver cancer risk assessment. Patients with hepatitis B and early cirrhosis were called for liver cancer screening and risk assessment once in every six to twelve months. (July 08, 2010)

  • New blood test eliminates need for surgical lung biopsy for LAM diagnosis
    Researchers at the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center have found that a certain blood test can successfully identify lymphangioleiomyomatosis (LAM) in some patients, eliminating the need for surgical lung biopsy to make a diagnosis. (July 07, 2010)

  • A professor of Tsinghua University developes a gait machine for the paraplegia in clinical trials
    Recently, Professor Zhang Jichuan, from Rehabilitation Engineering Research Center of Tsinghua University, said that, cooperating with Beijing Rui Haibo Co., Ltd, he developed a gait machine for the paraplegia. (July 06, 2010)

  • PET/CT beats CT in NSCLC staging, but both have limitations
    While no imaging or invasive procedure is foolproof for staging non-small cell lung cancer (NSCLC), Danish researchers have found that PET/CT is more accurate than CT alone, though both modalities had a tendency to understage and overstage the cancer. (July 06, 2010)

  • Medical device Park starts in Wuhan Optical Valley
    Recently, Medical device Park in which Wuhan Hi-Tech Group invested started in Kowloon industrial base. Meanwhile, the field of projects such as reproductive health and family planning in the park were awarded the title of the first national industrial base. (July 05, 2010)

  • Gore receives European CE Mark approval for 25 cm GORE VIABAHN Endoprosthesis
    W. L. Gore & Associates (Gore) recently announced that it has received European CE Mark approval for the 25 cm GORE®VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface. (July 02, 2010)

  • A quality assessment system must be established for excessive heart stent surgery
    In China, there are 230 million patients with cardiovascular disease, of which every 10 seconds one person dies. Currently, heart stent surgery is so significantly increased that experts have called on to establish a quality assessment system for the surgery. (July 02, 2010)

  • Sensor integrated insulin pump for better blood sugar control
    Adding a continuous blood sugar level sensor to an insulin pump helps patients with type 1 diabetes achieve better blood sugar control compared to the common standard of care, multiple daily insulin injections. (July 01, 2010)

  • Scanning Acoustic Microscope of CETC filled the domestic gap of this technology
    Recently, the China Semiconductor Industry Association, China Electronics News and two other units jointly selected 36 items in the Fourth Chinese semiconductor innovative products and technology. (July 01, 2010)

  • The first magnetism-navigated interventional surgery with digital dual flat was operated in Shanghai
    Recently, dual flat detector imaging system in cardiovascular with magnetic navigation has been officially put into use in Zhongshan Hospital of Fudan University.Miss Xiao, the person who has severe coronary artery chronic total occlusion, became the first beneficiary. (June 30, 2010)

  • FDA grants AMS clearance for MiniArc Precise Single-Incision Sling System
    American Medical Systems® (AMS), a leading provider of world-class devices and therapies for both male and female pelvic health, recently announced FDA has cleared the MiniArc® Precise Single-Incision Sling System. (June 29, 2010)

  • Researchers say ear tubes are safe for children with cochlear implants
    Children who are being treated for hearing loss with cochlear implants can safely have ear tubes installed to help clear up infections, say researchers at the University of Alabama at Birmingham (UAB). (June 28, 2010)

  • The first case of pulmonary vein stenosis stent implantation was successfully implemented in China
    Recently, Shanghai Chest Hospital successfully conducted the first case of interventional treatment of pulmonary vein stenosis. Therefore, a dying patient who has three severe pulmonary vein stenosis regained a new life. (June 28, 2010)

  • SFDA's Management Center for Medical Device Standards was unveiled
    On March 30, 2010, the unveiling ceremony for the Management Center for Medical Device Standards of SFDA was held in National Institute for the Control of Pharmaceutical and Biological Products (NICPBP). (2010年06月23日)

  • Asia-Pacific Healthcare Market To Grow
    The Asia-Pacific healthcare market has recorded a solid growth over the past decade. According to available statistics, the healthcare markets are projected to grow from US$ 246 billion in 2009 to US$ 348 billion in 2012, accounting for close to 27% of the global market. (June 23, 2010)

  • Women receive greater clinical benefit from CRT-Ds than men: Study
    Boston Scientific Corporation recently announced results from a sub-analysis of the MADIT-CRT trial data that showed women received a greater clinical benefit from its cardiac resynchronization therapy defibrillators (CRT-Ds) than men. (June 23, 2010)

  • Artificial pancreas system reduces risk of nocturnal hypoglycemia
    An article recently published in The Lancet reports that using an artificial pancreas system overnight can significantly reduce the risk of nocturnal hypoglycemia in children and adolescents with type 1 diabetes. (June 23, 2010)

  • Medtronic's anatomically-designed ablation catheters reduce lab time for PVI
    Data from the FAST-PVI study, supported by Medtronic, Inc, shows lab time using anatomically-designed ablation catheters are more than one-third (35 percent) faster than traditional point-by-point focal ablation procedures in achieving pulmonary vein isolation (PVI). (June 21, 2010)

  • Dabl's computerised system prevents misdiagnosis of ABPM
    An independent study has revealed that Irish Company, dabl's computerised system for diagnosing 24 hour blood pressure is more accurate and consistent than a leading group of international hypertension experts. (June 18, 2010)

  • New handheld biometrics device offers rapid dual-iris image capture
    Black Diamond Advanced Technology has designed and delivered to Northrop Grumman a ruggedized, identity-management system for secure and efficient multi-modal biometrics collection in the field. (June 17, 2010)

  • Cook Medical files for PMA of Zilver PTX Drug-Eluting Peripheral Stent with FDA
    Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the company's unique polymer-free Zilver® PTX® Drug-Eluting Peripheral Stent. (June 17, 2010)

  • QBC Diagnostics launches SureFocus Microscope Slide for detection of tuberculosis bacteria
    QBC Diagnostics is pleased to announce the release of the SureFocus Microscope Slide, a breakthrough in the detection of tuberculosis bacteria. (June 13, 2010)

  • Medtronic launches iPro2 Professional CGM system to help improve diabetes management
    Medtronic, Inc. announced recently the launch of iPro™2 Professional CGM, a continuous glucose monitoring (CGM) system used by physicians to help improve diabetes management, in 49 countries around the world. (June 13, 2010)

  • FDA approves 45mm GORE TAG Thoracic Endoprosthesis device
    W. L. Gore & Associates recently announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market a 45 mm diameter version of the GORE® TAG® Thoracic Endoprosthesis for treatment of aneurysms of the descending thoracic aorta. (June 12, 2010)

  • Chronix' DNA blood tests detect prostate, breast cancer with 92% sensitivity and 100% specificity
    Chronix Biomedical recently reported new data further demonstrating that its DNA blood tests have the potential to accurately detect early stage breast and prostate cancers. Chronix's proprietary technology identifies disease-specific genetic fingerprints based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells. (June 12, 2010)

  • TMI announces development of new clinical imaging system
    With the results of the clinical trial at Duke University Medical Center completed, and the pending publication of the results, TMI is pleased to announce the development of their new clinical imaging system. (June 11, 2010)

  • Integra LifeSciences announces over 800 implantations of Vu a-POD fusion device
    Integra LifeSciences (Nasdaq:IART) announced recently a major milestone in the commercialization of the Vu a-POD™ anterior lumbar intervertebral body fusion (ALIF) device. Launched in the U.S. in early 2009, the Vu a-Pod™ fusion device has now been implanted in over 800 patients in the U.S. (June 11, 2010)

  • Students develop innovative optical radar system to help blind people maneuver around obstacles
    Ben-Gurion University of the Negev students have developed an innovative optical radar system that helps blind people maneuver around obstacles.The radar system incorporates a computer, two video cameras and a scanning light source to warn the blind of obstacles with audible alerts. (June 09, 2010)

  • Roche's new dual-PCR target HIV-1 viral load test receives FDA approval
    Roche Molecular Diagnostics announced recently that the Food and Drug Administration (FDA) approved its new dual-PCR target HIV-1 viral load test to quantify the amount of virus in a patient's blood. (June 08, 2010)

  • Siemens Healthcare donates MAGNETOM ESSENZA MRI system to Phoebe Sumter Medical Center
    After three long years of hardship to rebuild a cornerstone of the community, the staff of Phoebe Sumter Medical Center welcomed the arrival of a new MAGNETOM® ESSENZA magnetic resonance imaging (MRI) system, compliments of Siemens Healthcare. (June 08, 2010)

  • KCI to submit labeling for its products cleared by FDA for home use
    Kinetic Concepts, Inc. recently announced it is the first manufacturer to commit to submitting labeling for its products used in the home to the Food and Drug Administration as part of the agency's medical device Home Use Initiative. (June 07, 2010)

  • EHSI develops new iPhone app to reduce medication errors for senior citizens
    Emerging Healthcare Solutions, Inc. (Pink Sheets:EHSI) announced recently that a new breakthrough iPhone app is being developed to dramatically reduce medication errors for senior citizens. Millions of seniors in America take a confusing array of medications to improve their quality of life. (June 07, 2010)

  • Oncimmune develops new blood test to aid early detection of cancer
    The University of Nottingham spin-out company, Oncimmune Ltd, has developed a ground breaking blood test which will aid the detection of cancer as much as five years earlier than current testing methods such as mammography and CT scans. Physicians will know the result of their patient's test within one week of sending in a blood sample to Oncimmune. (June 04, 2010)

  • Cook's Resonance Metallic Ureteral Stent demonstrates long-term success in 29-month clinical study
    A 29-month clinical study demonstrated the long-term success of Cook Medical's Resonance® Metallic Ureteral Stent in providing drainage for patients with both benign and malignant upper urinary tract obstructions, according to results presented today at the 2010 Annual Meeting of the American Urological Association (AUA). (June 04, 2010)

  • Concentric Medical receives expanded indication for DAC family of neurovascular catheters
    Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, recently announced an important expanded indication for the full line of DAC™ Neurovascular Catheters. CE Mark was granted allowing the DAC family of distal access catheters to be used for the removal/aspiration of fresh, soft emboli and thrombi from vessels in the arterial system, including the neurovasculature. (June 03, 2010)

  • Oculus launches Microcyn Negative-Pressure Wound Therapy Solution
    Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, recently introduced the Microcyn Negative-Pressure Wound Therapy Solution™ for the U.S. professional healthcare market. Within the pH ranges of 6-7.8 desired for optimum negative-pressure wound therapy, Microcyn is intended for the irrigation and management of wounds via these advanced systems. (June 03, 2010)

  • GE Healthcare introduces new CESM technology to aid in breast cancer diagnosis
    GE Healthcare (NYSE:GE), a pioneer in digital mammography, reccently announced the introduction of an innovative technology to aid in breast cancer diagnosis. GE Healthcare's new SenoBright Contrast Enhanced Spectral Mammography (CESM) technology reduces ambiguity in mammography results, enabling physicians to detect and diagnose cancer with more confidence - even in the densest part of the breast tissue more rapidly and accurately. (June 02, 2010)

  • Cook Medical launches BIGopsy Backloading Biopsy Forceps for accurate diagnosis of kidney cancers
    Urologists treating patients with suspicious ureteral or kidney lesions now have a tool to help them more effectively make diagnoses. Cook Medical has introduced the BIGopsy Backloading Biopsy Forceps, a device designed and engineered to obtain large renal or ureteral tissue specimens up to 4 mm3 for cancer diagnosis. The larger sample size helps produce biopsy results without the need for repeat tissue-sampling procedures associated with other biopsy devices. (June 01, 2010)

  • New GreenLight XPS Laser System launched for treatment of BPH
    American Medical Systems® (AMS), a leading provider of world-class devices and therapies for both male and female pelvic health, recently announced the launch and immediate availability of its new GreenLight XPS (Xcelerated Performance System) for laser treatment of benign prostatic hyperplasia (BPH) or enlarged prostate. (June 01, 2010)

  • Sutter General performs first hip replacement with ROBODOC Surgical System after FDA clearance
    Eighteen years ago, orthopedic surgeon William Bargar, M.D. made history when, at Sutter General Hospital in Sacramento, he performed the first-ever hip replacement using a robotic device he developed called ROBODOC®, which improves precision in joint replacement surgery. Warren Roberts of Davis was among Dr. Bargar's first patients; in 1995, he underwent replacement of his left hip as a part of an FDA study using ROBODOC®. (May 31, 2010)

  • A Medical Center in California uses Arctic Sun cooling device to protect a patient from brain damage
    Desperate to save the life of the young mother, the cardiac arrest team performed 95 minutes of CPR. Then thoracic surgeon John Eugene, MD operated to remove the blood clots. Still, Ms. Ervin lay comatose, her neurologic prognosis extremely poor. The doctors and nurses knew one therapy might save her ?C therapeutic hypothermia, but Anaheim Regional did not yet own an Arctic Sun® cooling device. (May 28, 2010)

  • Stentys receives CE Marking for drug-eluting stent
    Stentys announced recently that it has received CE Marking for its drug-eluting stent."The clinical results of the Stentys DES in complex lesions have been spectacular, and we are thrilled that patients throughout Europe will have access to the benefits of our self-expanding stent in due course". (May 27, 2010)

  • Boston Scientific collaborates with Philips, Siemens to offer integrated imaging systems
    Boston Scientific Corporation recently announced collaborations with Philips Healthcare and Siemens Medical Solutions to enable the use of its iLab® Ultrasound Imaging System with the Philips Allura™ Xper and the Siemens AXIOM™ Artis and Artis™ zee interventional X-ray systems. (May 27, 2010)

  • Waters introduces new TQ-S and G2 QTof mass spectrometers for Xevo MS platform
    Waters Corporation (NYSE: WAT) introduced recently two new mass spectrometers for its Xevo MS platform ?C the Xevo TQ-S and Xevo G2 QTof ?C that bring a step change in performance to benchtop mass spectrometry. The product introductions were made at the 58th annual meeting of the American Society for Mass Spectrometry (ASMS). (May 26, 2010)

  • Researchers develop new device that can change current landscape of chronic wound management
    A new breakthrough device developed by researchers can change the current landscape of chronic wound management. Researchers at Drexel University's School of Biomedical Engineering, Science and Health Systems developed a prototype device that measures the level of oxygenated and deoxygenated hemoglobin within and under a wound and compares it to a control/non-wound site of the same patient. (May 26, 2010)

  • New online diagnosis tool offers prescriptions in a hurry
    A new venture called Zipnosis allows patients to receive diagnoses and prescriptions online for $25, The Star Tribune reports. "Minneapolis-based Zipnosis thinks it is onto the latest innovation in convenient health care for minor ailments like common colds, allergies or bladder infections. (May 25, 2010)

  • Medtronic commences treatment of Valiant Thoracic Stent Graft with Captivia Delivery System
    Further demonstrating its commitment to proving the benefits of minimally-invasive procedures, Medtronic, Inc., recently announced that the first patient has been treated with the company's Valiant® Thoracic Stent Graft with the Captivia Delivery System in Medtronic's RESCUE Clinical Study. (May 24, 2010)

  • EPFL develops flowing 3D model of cardiovascular system that predicts heart attacks
    EPFL Laboratory of Multiscale Modeling of Materials, in Switzerland, has developed a flowing 3D model of the cardiovascular system that should allow for predictions of certain heart diseases before they become dangerous. (May 24, 2010)

  • IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe
    IDEV Technologies, Incorporated, (IDEV) an emerging leader in the development and marketing of minimally invasive medical technologies, recently announced the European launch of the SUPERA VERITAS™ Peripheral Vascular System, a novel and innovative stent delivery system designed to be reliable, easy to use and precise. (May 21, 2010)

  • FDA grants LensAR Laser System 510(k) clearance for use in anterior capsulotomy
    LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, recently announced that the company has received 510(k) clearance from the FDA for use of the LensAR Laser System for anterior capsulotomy during cataract surgery. (May 21, 2010)

  • Varian Medical Systems launches fully-integrated ProBeam proton therapy system at 2010 PT-COG
    Varian Medical Systems is introducing the fully-integrated ProBeam™ proton therapy system at the 2010 Particle Therapy Co-operative Group (PT-COG) meeting here this week. The ProBeam system incorporates imaging, gating, robotic patient positioning, treatment planning and oncology information software to enhance treatment quality for patients and workflow efficiency for clinicians. (May 21, 2010)

  • Covidien launches SILS stitch suturing device for advanced laparoscopic surgery
    Covidien, a leading global provider of healthcare products, recently announced the worldwide launch of the SILS™ Stitch articulating suturing device for advanced laparoscopic surgery, including SILS single-incision procedures. The SILS Stitch instrument expands the Company¡¯s SILS product line, as well as its endoscopic suturing portfolio, which includes today¡¯s leading automated endosuturing product, the Endo Stitch™ instrument and reloads. (May 21, 2010)

  • AngioDynamics launches Morpheus Smart PICC Triple Lumen CT PICC
    AngioDynamics announced recently the launch of the first member of its new generation of peripherally inserted central catheters (PICCs) for procedures involving the use of contrast media in computed tomography (CT) - the Morpheus Smart PICC Triple Lumen CT PICC. (May 19, 2010)

  • Dehaier Medical Systems becomes exclusive China distributor of Welch Allyn's patient monitors
    Dehaier Medical Systems Ltd. (Nasdaq: DHRM), an emerging leader in the development, assembly, marketing and sale of medical products in China, said recently that it has become the exclusive China distributor of Welch Allyn's patient monitors. (May 19, 2010)

  • Cardiocom releases new pulse oximeter
    Cardiocom recently announced the release of its new pulse oximeter. Cardiocom's internally developed pulse oximeter offers better integration with its telehealth platform. Cardiocom designs and manufactures telehealth communication devices and vital sign peripherals including: blood pressure system, weight scale, and now offers its new pulse oximeter. (May 18, 2010)

  • Still River Systems announces clinical beam extraction from world's smallest high-energy proton ther
    Still River Systems, Inc. announces successful clinical beam extraction from the first production unit of the world's smallest high-energy proton therapy accelerator. Powerful proton beams are used for the precise treatment of cancer by delivering a highly focused beam of radiation to the tumor while reducing the damage to surrounding healthy tissue and vital organs. (May 17, 2010)

  • New wearable impact sensor monitors athletes' performance
    As athletes strive for perfection, sports scientists need to exploit every technological advance to help them achieve that goal. Researchers in New Zealand have now developed a new type of wearable impact sensor based that can provide much needed information about the stresses and strains on limbs for rugby players, high jumpers, and runners. (May 17, 2010)

  • Aesculap Implant Systems introduces S4 Element Pedicle Screw System
    Aesculap Implant Systems, LLC is pleased to announce the launch of the S4® Element™ Pedicle Screw System.The S4 Element Pedicle Screw System was made available to a select group of surgeons since May of last year as part of the company's Market Preference Evaluation, and a full launch of the system is planned for the second quarter of 2010, at which time the system will be released to surgeons throughout the United States. (May 14, 2010)

  • New disposable measuring device monitors body's vital functions
    Alongside the implantable measurement device, researchers from Tampere University of Technology have developed an instrument that measures vital functions, such as EKG, directly from the skin surface (May 14, 2010)

  • Medtronic announces new M-Link cellular accessory
    Medtronic, Inc. (NYSE: MDT) announced recently that it now offers the new Medtronic M-Link™ cellular accessory, which provides cardiac device patients with an option to securely send information stored in their implanted devices to their clinics via the CareLink® Network using cellular signals, rather than a telephone landline. This simplified connection to the CareLink® Network enables clinicians to remotely monitor more patients who are implanted with cardiac devices. (May 14, 2010)

  • BD Biosciences introduces new Influx Cell Sorting System
    BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced recently the launch of the new BD Influx™ Cell Sorting System that researchers can configure with up to seven lasers to support two-way, four-way and six-way sorting, giving them flexibility to meet specific application or environmental requirements. (May 12, 2010)

  • Olympus launches OER-Pro automated endoscope reprocessor
    Olympus, a precision technology leader, designing and delivering innovative solutions in medical and surgical products, recently announced the launch of the OER-Pro, the fastest technology in automated endoscope reprocessing and the only reprocessor on the market designed by an endoscope manufacturer. (May 12, 2010)

  • Roche launches cobas(R) 4800 System in Canada for testing CT, NG and HPV
    Roche Diagnostics Canada (SIX: RO, ROG; OTCQX: RHHBY) announced recently the launch of a new Health Canada approved clinical laboratory system designed to increase laboratory testing efficiency and to accommodate current and long-term molecular diagnostic needs. (May 10, 2010)

  • Home-based medical devices to grow over 1.6M by 2013
    Emerging Healthcare Solutions, Inc. applauded the results of a new report from InMedica on the world market for telemedicine, predicting that the use of home-based medical devices will drastically increase as telemedicine takes-off. (May 10, 2010)

  • Dehaier Goes Public Stock Trades on NASDAQ
    Dehaier Medical System has successfully finished the IPO in the US, while the company was listed on NASDAQ on April 22nd, 2010. Its shares is trading under the stock symbol Nasdaq: DHRM. Dehaier develops, makes and sells home respiratory and oxygen products and other medical devices in China. (May 10, 2010)

  • Surgeons can now customize artificial knee implants, prevent future revision surgeries
    Throughout the years orthopedic surgeons have learned that one size does not fit all when it comes to joint replacements. Because of advancements in technology, surgeons can now customize artificial knee implants and prevent future revision surgeries. (May 07, 2010)

  • New tool may help neurologists predict candidates for organ donation
    A new tool may help neurologists predict which coma patients may be candidates for organ donation, according to a study published in the April 27, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology. (May 07, 2010)

  • BioMedica Diagnostics' flagship product monitors heart disease
    BioMedica Diagnostics Inc, a company that uses innovative technology to link the medical needs of developed countries with those of less advantaged populations is growing. Its flagship product QuikCoag is being exported to over 30 countries around the world for monitoring the growing prevalence of heart disease. (May 06, 2010)

  • New 3-D mapping and labeling system reduces scan time and improves work flow
    Researchers have developed an automated 3-D mapping and labeling system that reduces scan time and improves the work flow, efficiency, and accuracy of routine freehand ultrasound exams, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA. (May 06, 2010)

  • ExacTrac SV system allows precise targeting of radiotherapy using real-time X-ray images
    A system that allows precise targeting of radiotherapy using real-time X-ray images has allowed French doctors to increase the dose of radiation they administered to lung and liver cancers while minimizing harm to nearby healthy tissue, researchers report at the 2nd European Lung Cancer Conference. (May 05, 2010)

  • Computer-based system automatically tracks radiation dose exposure in patients receiving CT scan
    Researchers have developed a computer-based system that can automatically track patient-specific radiation dose exposure (based on a patient's size and weight) on every patient that receives a computed tomography (CT) scan, providing patients with a way to start tracking their cumulative health care-related radiation exposure, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA. (May 05, 2010)

  • Computer-based system automatically tracks radiation dose exposure in patients receiving CT scan
    Researchers have developed a computer-based system that can automatically track patient-specific radiation dose exposure (based on a patient's size and weight) on every patient that receives a computed tomography (CT) scan, providing patients with a way to start tracking their cumulative health care-related radiation exposure, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA. (May 04, 2010)

  • Physicists and oncologists to develop novel ultra sensitive platform for early cancer detection
    The SPEDOC project will create the precursor to future devices for individualized diagnosis and monitoring of cancer therapy, which will allow the illness to be treated in earlier stages and at lower doses, reducing or preventing current secondary effects. (May 04, 2010)

  • Alair Bronchial Thermoplasty System receives FDA approval to treat asthma in adults
    The U.S. Food and Drug Administration recently approved the first medical device that uses radiofrequency energy to treat severe and persistent asthma in certain adults. (April 30, 2010)

  • FDA issues warning over faulty components in external defibrillators
    About 280,000 external defibrillators used worldwide in health care facilities, public places, or in the home may malfunction during attempts to rescue people in sudden cardiac arrest, the U.S. Food and Drug Administration warned recently. (April 30, 2010)

  • Bayer Diabetes Care announces US launch of DIDGET blood glucose monitoring system
    Bayer Diabetes Care recently announced the introduction of the DIDGET blood glucose monitoring system in the United States. The DIDGET meter is unique because it is the only blood glucose meter that connects directly to Nintendo DS and DS Lite gaming systems to help kids manage a lifelong disease by rewarding them for building consistent testing habits and meeting personalized blood glucose target ranges. (April 29, 2010)

  • ThermaCor 1200 Rapid Thermal Infusion System used successfully in multiple clinical cases
    Smisson-Cartledge Biomedical LLC (SCB), an innovator in life saving cardiovascular devices, announced recently that its ThermaCor 1200 Rapid Thermal Infusion System has been used successfully in multiple clinical cases in the United States and in the Kingdom of Saudi Arabia. (April 29, 2010)

  • GE targets ultrasound energy reduction
    GE Healthcare is joining with other medical device manufacturers to commit to a 25% reduction in average energy consumption of new ultrasound products by 2012. (April 29, 2010)

  • Medtronic receives FDA 510(K) clearance for PoleStar N30 Surgical MRI system
    Medtronic (NYSE: MDT) recently announced U.S. Food and Drug Administration (FDA) 510(K) clearance and U.S. launch of the PoleStar® N30 Surgical MRI system, the latest in neuro oncology surgical solutions. (April 27, 2010)

  • Beijing Customs seize Biosite's Triage products
    Biosite's Triage products imported by Inverness Medical Beijing Co., Ltd. in April 2010 have been seized by Beijing Customs for not complying with the applicable importation regulations. As a result, the Chinese market is facing a severe shortage. (April 27, 2010)

  • Adjusting the radiation dose based upon a child's weight can significantly lower the radiation dose
    Adjusting the radiation dose based upon a child's weight can significantly lower the radiation dose associated with pediatric chest computed tomography (CT) scans, according to a study published in the May issue of the American Journal of Roentgenology. CT scanning combines special X-ray equipment with sophisticated computers to produce multiple images or pictures of the inside of the body. (April 26, 2010)

  • SpectraCell Laboratories introduces apolipoprotein E genotyping
    Effective immediately, SpectraCell Laboratories now offers apolipoprotein E genotyping. This test determines a person's genetic risk for heart disease associated with the commonly studied gene called apoE, which is involved in the metabolism of cholesterol and triglycerides (fats in the blood). (April 26, 2010)

  • Cook Medical enrolls first patient in Formula PTX Balloon Expandable Renal Stent trial
    Angiotech Pharmaceuticals, Inc. recently announced Cook Medical, a license holder of Angiotech's paclitaxel technology, has enrolled the first patient in its landmark Formula(TM) PTX(R) clinical trial. The trial is the first of its kind to evaluate the safety and effectiveness of a paclitaxel-eluting stent to treat renal artery disease, the narrowing of the arteries that supply blood to the kidneys. (April 23, 2010)

  • FDA approves Medtronic's Complete SE Vascular Stent System for PAD
    Broadening the scope of innovation for cardiovascular interventions beyond the heart, Medtronic, Inc., announced recently that it has received approval from the U.S. Food and Drug Administration (FDA) for the Complete® SE Vascular Stent System to be used for the treatment of peripheral arterial disease (PAD) in the iliac arteries, major blood vessels within the pelvis that supply blood to the lower extremities. (April 23, 2010)

  • Endra Life Sciences Launches First Ever Commercial Photoacoustic 3-D Tomographic Imaging System
    Endra Life Sciences announced the launch of the Nexus 128, a preclinical photoacoustic computed tomography (CT) scanner for small animal imaging. The system is used for simple, fast, non-invasive quantification of tumor vasculature and other physiological parameters for preclinical research. (April 21, 2010)

  • New cardiac CT technology promises low radiation exposure and improved image quality
    Cardiovascular disease is the leading cause of death globally and a tremendous burden on the healthcare system. Better detection of hardening or clogging of arteries and other blood vessels before symptoms occur is needed. (April 21, 2010)

  • Artificial pancreas system succeeds in maintaining near-normal glucose levels
    An artificial pancreas system that closely mimics the body's blood sugar control mechanism was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of patients. The system, combining a blood glucose monitor and insulin pump technology with software that directs administration of insulin and the blood-sugar-raising hormone glucagon, was developed at Boston University (BU). (April 19, 2010)

  • Varian Introduces New TrueBeam System For High-Precision Image-Guided Radiotherapy And Radiosurgery
    Varian Medical Systems is announcing the introduction of a new line of "super" accelerators designed to advance the treatment of lung, breast, prostate, head and neck, and other types of cancer. (April 19, 2010)

  • Carestream Molecular Imaging, OncoVision sign exclusive agreement
    Carestream Molecular Imaging, a division of Carestream Health, Inc., has signed an exclusive, multi-year worldwide agreement with OncoVision (Valencia, Spain), to sell, market and service the Albira PET/SPECT/CT imaging system for small animal research. With the addition of this innovative, multimodal imaging system. (April 16, 2010)

  • GE Healthcare Presents Positive Phase 2 Data With Flutemetamol Phase 3 Program Now Underway
    GE Healthcare will present results from its multicenter phase 2 study of flutemetamol at the 4th annual Human Amyloid Imaging (HAI) Meeting in Toronto, Canada. Flutemetamol is a positron emission tomography (PET) imaging agent in development by GE Healthcare, in the field of brain imaging. (April 16, 2010)

  • BIOTRONIK receives European approval for new ProMRI Pacing Systems
    ¡°We are very pleased to offer physicians the choice to select from a series of the most technologically advanced pacemakers ¡ª the Evia series of pacemakers ¡ª and at the same time give their patients access to MRI diagnostic procedures¡± (April 14, 2010)

  • Oraya Therapeutics' IRay stereotactic radiotherapy system granted European CE Mark approval
    Oraya Therapeutics, Inc. announces recently that a leading European notified body has granted approval to designate the CE mark to Oraya's IRayTM stereotactic radiotherapy system. (April 14, 2010)

  • FDA turns attention to radiation therapy devices
    The FDA sent letters to 93 makers of radiation treatment devices, urging them to attend a workshop to address concerns about patient exposure to excess radiation from medical treatments and procedures. (April 12, 2010)

  • Simple Ultrasound Test Improves Diagnosis Of Heart Disease
    New research shows that doing a simple ultrasound scan of the carotid artery significantly improves the prediction of heart disease, giving doctors a better clue of who is at high risk for a heart attack. (April 12, 2010)

  • FDA-approved contrast agent improves optical imaging of stem cells
    A study published in the current issue of Cell Transplantation (19:1) has found that using the FDA-approved contrast agent Indocyanine Green (ICG) to label human embryonic stem cell-derived cardiomyocytes (hESC-CMs) substantially improved efforts to optically track stem cells after transplanting them into heart tissues. (April 12, 2010)

  • Electronic nose may help identify asthma in patients: CHEST
    New evidence shows that an "electronic nose" containing an array of gas sensors may have the ability to identify asthma in patients. Researchers from Italy compared the diagnostic performance of the electronic nose with lung function tests and fraction of exhaled nitric oxide (FENO) in seven patients with asthma and seven healthy subjects. For each person, the electronic nose analysis was performed on total exhaled air and alveolar air. (April 09, 2010)

  • FDG PET may help identify patients who would benefit from bypass surgery
    For a patient with heart failure, checking whether the heart could benefit from bypass surgery or a stent is critical to ensuring survival. One imaging technique, positron emission tomography (PET) with the imaging agent fluorodeoxyglucose (FDG), may provide doctors with the information they need to make more informed treatment decisions. (April 09, 2010)

  • FDA clears Sysmex America's XT-4000i Automated Hematology Analyzer
    Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and information systems developer, recently announced that its Sysmex XT-4000i Automated Hematology Analyzer has been cleared by the United States Food and Drug Administration (FDA). (April 07, 2010)

  • ProUroCare Medical receives FDA letter regarding prostate imaging system premarket application
    ProUroCare Medical Inc. announced recently that on March 29, 2010 a letter was received from the FDA regarding the pending 510(k) premarket application for the Company's ProUroScan prostate imaging system. The letter indicated that the FDA could not complete its review because they believed an appropriate predicate device had not been identified. (April 07, 2010)

  • KCI launches V.A.C. ATS Therapy System in Japan
    Kinetic Concepts, Inc. has announced the first patient placement of the company's innovative V.A.C.® ATS Therapy System in Japan. This landmark event represents the commercial launch of the therapy in Japan and the beginning of a comprehensive market development strategy in the country. (April 06, 2010)

  • Neurologist develops SAGE tool to diagnose memory disorders
    A self-administered test to screen for early dementia could help speed the diagnosis and subsequent treatment of memory disorders, including Alzheimer's disease. It could also provide health care providers and caregivers an earlier indication of life-changing events that could lie ahead. (April 06, 2010)

  • Cook Medical to feature its Goldstein SonoBiopsy Catheter at 2010 AIUM convention
    With over 10 million women in the U.S. suffering from endometrial disorders like abnormal uterine bleeding or uterine fibroids, the 2010 American Institute of Ultrasound Medicine (AIUM) convention will feature specialized programs and product showcases highlighting imaging solutions available to better diagnose these conditions. Cook Medical will feature its Goldstein SonoBiopsy™ Catheter, a uniquely designed device for diagnosing the cause of abnormal uterine bleeding. (April 01, 2010)

  • New PreXion3D Volumetric Imaging Software for 3D CBCT system launched
    PreXion, Inc., the leader in high quality 3D Cone Beam Imaging systems for dentistry, recently announced that it has launched and started shipping new PreXion3D Volumetric Imaging Software for its 3D Cone Beam Computed Tomography system for dentistry. (April 01, 2010)

  • New devices pave way for applications in cardiology and neurology
    A team of cardiologists, materials scientists, and bioengineers have created and tested a new type of implantable device for measuring the heart's electrical output that they say is a vast improvement over current devices. The new device represents the first use of flexible silicon technology for a medical application. (April 01, 2010)

  • ForeverGreen Worldwide completes in-house information systems
    ForeverGreen Worldwide Corp. (OTCBB: FVRG) announces the completion of its in-house fully functional information systems. (April 01, 2010)

  • Leap Medical secures seed financing to develop innovative technology for detection of brain injuries
    Leap Medical Inc., a privately held Medical Device company, announced recently that it has successfully secured seed financing in the amount of $1.025 million (Canadian dollars) to develop its innovative technology for the rapid detection of brain injuries and infection. (March 29, 2010)

  • IMRISNV and IMRIScardio systems get Australian TGA clearance
    IMRIS Inc. recently announced that it has received clearance from Australia's Therapeutic Goods Administration permitting the Company to market its newest products, IMRISNV and IMRIScardio in Australia. (March 29, 2010)

  • FDA approves expanded indication for Boston Scientific's CRT-Ds
    Boston Scientific Corporation (NYSE: BSX) recently announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D. (March 24, 2010)

  • SoCalBio to host discussion on latest medical devices for treating obesity
    The Southern California Biomedical Council (SoCalBio) will host a discussion on the latest medical devices for treating obesity during its networking forum on Thursday, March 25th (7:00 - 9:30 am) at the UC Irvine University Club. (March 24, 2010)

  • FDA panel favors approval with conditions of Medtronic's Revo MRI SureScan pacing system
    Medtronic, Inc. (NYSE:MDT) recently announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has voted unanimously in favor of approval with conditions of the Revo MRI™ SureScan™ pacing system designed as MR Conditional, or safe for use in Magnetic Resonance Imaging (MRI) systems under specified conditions. (March 24, 2010)

  • New device detects bacterial and fungal contamination
    Microorganisms are everywhere and most of them are harmless, but they can do a lot of damage in the manufacture of pharmaceuticals or in tissue transplants. With the aid of a new device, germs can be detected in artificial cartilage within a few hours. (March 24, 2010)

  • Portable ultrasound device to treat chronic joint pain from arthritis
    In recent years, doctors have used ultrasound to effective treat joint pain from arthritis and other ailments without the use of drugs. The drawback to these treatments, however, is that they can only be administered in a doctor's office or clinic, since the ultrasound devices currently used are bulky and expensive. (March 22, 2010)

  • FDA advisory panel recommends approval for Boston Scientific's CRT-D
    A new therapy that reduces the risk of mortality and heart failure in patients with mild cardiac disease received a thumb's up last week from an advisory panel to the U.S. Food and Drug Administration. (March 22, 2010)

  • UVA Health System offers Gamma Knife eXtend system to treat patients with head and neck cancer
    A powerful new tool available at the University of Virginia Health System offers treatment to patients with some of the most challenging cancers of the head and neck. (March 19, 2010)

  • BioVigil's second generation hand hygiene monitoring system released
    BioVigil LLC has released the second generation of the BioVigil hand hygiene monitoring system. The innovative system enables hospitals to more effectively combat Hospital-Acquired Infections (HAIs) by dramatically increasing hand hygiene compliance among healthcare workers. (March 19, 2010)

  • Cook Medical launches new NavAlign femoral delivery system at SIR Annual Scientific Meeting
    Physicians placing inferior vena cava (IVC) filters to prevent life-threatening pulmonary emboli now have access to the latest iteration of Cook Medical¡¯s advanced NavAlign™ delivery system, a deployment system designed to minimize the risk of vessel trauma and streamline filter placement. (March 17, 2010)

  • Cordis launches PRESILLION PLUS bare metal stent system in Europe
    Cordis Corporation recently announced the European launch of its next generation of bare metal stent system - PRESILLION(TM) PLUS. The new stent system, which improves upon the ground-breaking PRESILLION(TM), features important technological advances designed to gain easier access to distal lesions and help restore the artery's natural form. (March 17, 2010)

  • Rex Medical receives FDA Clearance for Cleaner Rotational Thrombectomy System
    Rex Medical, L.P., recently announced that it has received 510(k) Clearance from the U.S. Food and Drug Administration (FDA) for the Cleaner™ Rotational Thrombectomy System. Cleaner™ technology is indicated for mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis access grafts. Argon Medical Devices, Inc. will lead all marketing and distribution efforts for Cleaner™ in the United States, European Union and Canada. (March 15, 2010)

  • Medtronic Introduces The Vertex Select(R) Reconstruction System
    Medtronic, Inc. (NYSE: MDT) announced the U.S. launch of the VERTEX SELECT® Reconstruction System.When a patient has a spinal condition that requires fusion or a procedure that must be performed from the back of the spine, also known as a posterior approach, the VERTEX SELECT® Reconstruction System contains implants and an instrument set for performing this surgical procedure. (March 15, 2010)

  • Smith & Nephew launches TWINFIX Ultra PK Suture Anchor for rotator cuff repair
    Smith & Nephew's (NYSE: SNN; LSE: SN) Endoscopy Division recently announced the introduction of the TWINFIX™ Ultra PK Suture Anchor, a new anchor to address wide variation in bone density and tissue quality for rotator cuff repair in the shoulder. The device is currently being featured at Smith & Nephew Endoscopy's booth at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting in New Orleans. (March 12, 2010)

  • Yunnan will implement the Inspection Standards for Medical Device Enterprises
    "Yunnan Province Inspection and Acceptance Standard for Medical Equipment Enterprises" will be put into effect since February 1, 2010. The "Standard" will provide policy support to further standardize the order of circulation of medical devices, purify medical device markets, and thus has symbolic significance for the development of circulation control of medical device in Yunnan. (March 12, 2010)

  • Mutual Recognition of Medical Test Results between Hospitals at Guangfo Hajime this Year
    Since January 1 this year, mutual recognition of part results of medical test and imaging examination will be carried out between 23 municipal general hospitals and some specialist hospitals at Guangfo Hajime. Mutually recognized items include the results of clinical examination, imaging test, endoscopy and pathological biopsy etc. (March 10, 2010)

  • Electronic Drug Testing Device was Settled in Shenzhen and Improved Efficiency of Drug Testing
    Owing to traditional drug testing data must be recorded and calculated on the paper and then it is input a computer one by one, so it is time-consuming and error-prone. A SDMS system recently checked and accepted by Shenzhen Food and Drug Administration has achieved simultaneous data-detecting and experiment which greatly improved the detection efficiency. Besides, this test house is the first institute that adopts the SDMS system in china. (March 10, 2010)

  • Researchers develop sensitive measuring system for cGVHD
    Researchers from The University of Texas M. D. Anderson Cancer Center have developed a new assessment tool to measure the severity of symptoms that can complicate stem cell transplantation. The tool assesses symptoms resulting from chronic graft-versus-host disease (cGVHD), and was presented with supporting research at the 2010 Bone and Marrow Transplant Tandem Meeting. (March 08, 2010)

  • Fujian's First Checkout Equipment of Ventilator has passed the inspection of the provincial bureau
    Recently, first checkout equipment of ventilstor developed by Fujian Institute of Metrology has passed the inspection of the provincial bureau. This approved checkout equipment of ventilstor can be used for metrological verification of ventilator. (March 08, 2010)

  • Guangdong will implement "Medical Device Production Management Representative System"
    Recently, at the "2010 Guangdong food and drug supervision work conference"held by Guangdong Food and Drug Administration, Chen Yuansheng pointed out that Guangdong will explore for implementing "Medical device production management representative system". (March 05, 2010)

  • Acculis' new device for destroying unwanted tissues receives European CE Mark clearance
    Acculis Limited recently announced the regulatory clearance of its revolutionary new device for destroying unwanted tissues, such as liver tumours. The clearance under the European CE Mark system allows the company to begin deliveries for treating patients throughout Europe and elsewhere where the CE Mark system is recognised. (March 05, 2010)

  • Zhengzhou Initiated Researches on the Prevention and Control Technology for New Influenza
    Zhengzhou City, in the shortest time, opened up a green channel and provided a 100 million of municipal technology research and development funding for the two researches on the prevention and control technology of new influenza. (March 04, 2010)

  • 2009 Research Report on Food and Drug Safety and Regulatory Policy has released in Beijing
    The book a provides a relatively comprehensive reflection of researches and progresses in food and drug safety and regulatory policy at all levels of government departments, agencies and at all sectors of society , particularly in the key explorations on improving the system and mechanism of food and drug safety supervision. (March 04, 2010)

  • Five Test units were certified to detect medical equipment products and projects by SFDA
    Recently, according to the provisions of "Supervision and Management Regulations of Medical Devices" and "Medical Equipment Testing Organizations Qualification Accreditation Approach (For trial implementation)" (State Drug Administration Registration Number:¡²2003¡³No. 125), an expert group of Chinese Food and Drug Administration respectively conducted a on-site assessment on the testing capability on medical device among 5 different testing organizations. (March 02, 2010)

  • MicroPort's new generation of Drug-eluting Coronary Stent Completed its First Human Implantation
    Firehawk rapamycin-eluting coronary stent, the latest product of MicroPort, has been first implanted into a patient's body at 10 o'clock on December 17, 2009 at the Fuwai Hospital successfully. (March 02, 2010)

  • China's Research on the key Techniques of Tumor Therapy with Heavy Ions has been Launched Formally
    The Research on the Key Techniques of Tumor Therapy with Heavy Ions, one of National Key Basic Research Development Program (973 Program) directed by researcher Zhanghong who is from the Institute of Modern Physics, Chinese Academy of Sciences, has been launched formally in Lanzhou, Gansu Province. (March 02, 2010)

  • Researchers develop noninvasive infrared scanning system to diagnose melanomas
    Johns Hopkins researchers have developed a noninvasive infrared scanning system to help doctors determine whether pigmented skin growths are benign moles or melanoma, a lethal form of cancer. (March 02, 2010)

  • Excimer Laser-Russian Surgical Equipment Settled in Beijing
    Recently, a whole set of Russian Microscan-Pic excimer laser surgical equipment was officially settled in Beijing Armed Police Corps Hospital, which is a good news for patients with eye disease in Beijing. According to the hospital official, the purpose of the introduction is to obtain the world's most advanced technology so as to enhance the level of treatment of eye disease. (February 22, 2010)

  • FDA may drop medical device 'fast track' amid overuse concerns
    The Food and Drug Administration may eliminate a program that allows medical devices to be approved quickly because of concerns the program is overused, The Wall Street Journal reports. (February 22, 2010)

  • The World's Most Advanced Diagnostic Equipment Settled in Beijing
    Malignant tumor is one of the major diseases that threat human health and life, nowadays, the prevention and control of cancer has become an important topic in today's medical community. However, if correct and reliable methods of early diagnosis are applied in the early cancer screening, then many malignant tumors will be treated satisfactorily. (February 20, 2010)

  • Chinese Academy of Sciences and Wave Group will jointly Develop Third-generation Sequencing Instrume
    To accelerate the process of Chinese gene research, recently, ¡°Beijing Genomics Institute of Chinese Academy of Sciences-Wave Group Genome Sciences Joint Laboratory¡± was established in Beijing. (February 20, 2010)

  • USPTO grants SPO Medical innovative baby heart rate monitoring patent
    SPO Medical Inc. (OTC: SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, recently announced it has been granted a new and innovative baby monitoring patent relating to a non-invasive device or system for monitoring and measuring the heart rate of a baby to activate an alarm when the level falls outside a predetermined range. (February 20, 2010)

  • Tryton Medical announces implantation of Tryton stent for the first time in Portugal and Austria
    Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the Tryton® stent has been implanted for the first time in Portugal and Austria. (February 20, 2010)

  • FDA's issues guidance on Bayesian statistical methods in medical device clinical trials
    The U.S. Food and Drug Administration today issued guidance on Bayesian statistical methods in the design and analysis of medical device clinical trials that could result in less costly and more efficient patient studies. (February 08, 2010)

  • Sorin Group announces first implant of FDA approved Paradym CRT Model 8750 defibrillator
    Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), a global leader in the treatment of cardiovascular disease, announced recently U.S. FDA approval and first implant of its next-generation of cardiac resynchronization therapy defibrillator (CRT-D), Paradym™ CRT Model 8750. (February 08, 2010)

  • China's First Self-developed Medical Neutron Irradiation Device
    China's first self-developed mini-type medical neutron irradiation device dedicated for the treatment of malignant tumors has reached its designed rating recently. Experts said this technique has created a unique platform for our country to catch up with and surpass international standards in the field of neutron capture therapy. (February 08, 2010)

  • "Medical Device Manufacturing Practices" has been promulgated recently
    Recently, "Medical Device Manufacturing Practices (for trial implementation)" has been promulgated by the State Food and Drug Administration and the ¡°Practices¡± will be put in force since January 1, 2011. (February 08, 2010)

  • FDA approves first heart valve conduit that can delay need for open-heart surgery
    The U.S. Food and Drug Administration today approved the Medtronic Melody Transcatheter Pulmonary Valve and Ensemble Delivery System, the first heart valve to be implanted through a catheter, or tube, in a leg vein and guided up to the heart. This new approach to the treatment of adults and children with previously implanted, poorly functioning pulmonary valve conduits can delay the need for open-heart surgery. (February 02, 2010)

  • Innovative cardiac scanner allows early detection of heart conditions
    An innovative cardiac scanner will dramatically improve the process of diagnosing heart conditions.The portable magnetometer is being developed at the University of Leeds, with funding from the Engineering and Physical Sciences Research Council (EPSRC) playing a key role. (February 02, 2010)

  • Stand-up MRI detects impact of heavy backpacks on children
    A stand-up MRI scanner found signs of lumbar spine compression in children carrying full backpacks, according to researchers from the University of California, San Diego (UCSD) School of Medicine. (February 02, 2010)

  • Cochlear implantation enables quality of life equal to normal hearing peers
    Children who have cochlear implants (CI) rank their quality of life (QOL) equal to their normally hearing (NH) peers, indicates new research in the February 2010 issue of Otolaryngology - Head and Neck Surgery. (February 02, 2010)

  • Zilver PTX Stent May Reduce Need for Leg Amputations and Bypass Surgery for Patients with PAD
    In a breakthrough development that may dramatically reduce the number of leg amputations and painful bypass graft surgeries performed annually on patients with peripheral arterial disease (PAD), a first-of-its kind drug-eluting stent is now available to physicians in Hong Kong. (January 29, 2010)

  • Siemens introduces its new imaging software, syngo.via
    At RSNA '09 Siemens introduced its new software, demonstrating the benefits it will have on advanced image reading, namely efficiency, integration, and ease-of-use. With syngo.via, the company is placing special focus on multimodality reading through automated case preparation and structured case navigation across multiple specialties, including cardiology, oncology, and neurology. syngo.via uniquely integrates imaging devices and IT. (January 27, 2010)

  • OrbusNeich's clinical data demonstrates the benefits of Genous Bio-engineered R stent
    OrbusNeich announced that clinical data presented recently at Asia PCR/Singapore LIVE 2010 demonstrated the benefits of the Genous Bio-engineered R stent in the treatment of two challenging patient subsets. (January 27, 2010)

  • Noncontrast CT accurately diagnoses acute appendicitis in adults
    "Noncontrast CT is advantageous because patients can be diagnosed more quickly, and there's no risk that a patient will have a bad reaction to the contrast material," first author Dr. Veronica Hlibczuk told Reuters Health. (January 26, 2010)

  • DHMC patient surveillance system decreases adverse events in postoperative care
    A simple yet enormously effective patient surveillance system implemented by anesthesiologists at Dartmouth-Hitchcock Medical Center (DHMC) in Lebanon, New Hampshire has proven to dramatically decrease the number of rescue calls and intensive care unit transfers in postsurgical patients, allowing doctors to intervene in more cases before a crisis situation develops. (January 26, 2010)

  • Insertion of tiny heart pump without surgery
    Cardiologists at the University of Illinois Medical Center at Chicago are leading the Midwest in offering improved treatment options to patients, from the most advanced techniques in angioplasty, to lowering the amount of radiation exposure during heart scans, to opening an innovative clinic that treats heart disease and depression together. (January 26, 2010)

  • St. Louis Children's Hospital installs Siemens' SOMATOM Definition AS CT scanner
    Recognized as one of the leading pediatric healthcare centers in the United States, St. Louis Children's Hospital in St. Louis is further enhancing its nationally renowned pediatric care program with the installation of a SOMATOM® Definition AS computed tomography (CT) scanner from Siemens Healthcare. (January 20, 2010)

  • Sword Diagnostics launches Raman detection system for ultrasensitive immunoassays
    Sword Diagnostics announced recently the launch of its proprietary Raman detection system for ultrasensitive immunoassays. The system provides researchers with greater sensitivity which enables more accurate testing of low abundance markers. These increases in performance could aid researchers in basic and clinical science research, drug discovery, and clinical diagnostics development. (January 20, 2010)

  • Japan's MHLW approves InSightec's ExAblate MRgFUS system
    InSightec Ltd. announced today that Japan's Ministry of Health, Labor and Welfare (MHLW) has approved the company's ExAblate(R) MR-guided Focused Ultrasound (MRgFUS) system for the treatment of women with uterine fibroids. (January 20, 2010)

  • Siemens promised to increase investment in the sustainable development of China's health care
    From December 6 to 9, 2009, on the occasion of Mr. Luo Xude, president and CEO of Siemens AG, led his members of executive committee to visit Beijing, Shanghai and other provinces and cities in China, accompanying by Prof. Rong Huaide, medical business CEO of Siemens and his management team, a series of co-operation projects with total investment of more than 750 million yuan has been successfully signed between the company and Chinese government and enterprises. (January 20, 2010)

  • China has successfully developed the first 10MeV small-sized cyclotron
    On December 27, 2009, China's first high-current cyclotron comprehensive testing device developed by China Institute of Atomic Energy (CIAE) has been successfully appraised by ¡°Technological Achievements Appraisal Meeting¡± held by the National Defense Science and Industry Bureau in Beijing. The cyclotron with designed energy of 10MeV can accelerate negative hydrogen ions, separate and elicit a 10MeV proton beam and its influx target current intensity can reach 430¦ÌA. (January 20, 2010)

  • SRLS launches new products to aid discovery and development of drugs and diagnostics
    SeraCare Life Sciences, Inc. (NASDAQ: SRLS) announced recently that the Company has added five new, differentiated products to its portfolio to meet the needs of SeraCare¡¯s growing customer base in the life sciences industry. (January 12, 2010)

  • China has successfully developed the world's first new combination-type artificial liver
    Recently, the National 863 Program and Guangdong Provincial Key Science and Technology Project---the world's first "new-generation of human-derived cell combination-type bio-artificial liver" has successfully developed by Zhujiang Hospital, Southern Medical University and received nine national patents. (January 11, 2010)

  • Jiangsu Aopu successfully developed infrared ear thermometer--taking body temperature within a second
    Recently, related personnel from Yangzhou Food and Drug Administration arrived at Gaoyou, Jiangsu to inspect at random the infrared ear thermometers produced by Jiang Su Aopu Medical Supplies Co., Ltd. for the prevention and control of influenza A (H1N1) virus and the results of inspection showed that all products were safe and effective. (January 06, 2010)

  • The first integrated artificial heart made in China will be available this year
    China invested 88 million yuan and successfully developed the first complete artificial heart which will be available this year, its core technology of the heart-blood pump, might have been or probably be able to successfully prolong Luojing¡¯s life, a well-known broadcaster of CCTV. (January 06, 2010)

  • Cook Medical's Women's Health Division Expands in China
    Cook Medical recently announces that its Women's Health Global Business Unit is expanding its emphasis on providing world-class medical care for female patients in China, particularly in the areas of high-risk obstetrics, gynecology and assisted reproductive technology (A.R.T.). (January 04, 2010)

  • First Painless Digestive Endoscopy Joint Training Center was officially established in China
    November 13, 2009, at the Digestive Disease Endoscopy Center, Xijing Hospital, Fourth Military Medical University, Xijing Hospital and Shenzhen Security Technology Co., Ltd. officially inaugurated a comfortable pain-free joint training Endoscopy Center. More than 40 participators such as directors of the center-Prof. Guo Xuegang and Prof. Sun Anhua et al attended opening ceremony. (December 31, 2009)

  • Prof. Minhua Zheng from Ruijin Hospital was elected as the new president of ELSA
    November 4-6th, 2009, the "9th Asian Endoscopic and Laparoscopic Surgery Annual Meeting" (ELSA 2009) was held in Xiamen. On November 5th, 2009, the Asian Society of Endoscopic and Laparoscopic Surgeons (ELSA) Director Plenary Session was held synchronously. (December 31, 2009)

  • Chinese Cord Blood Bank Enterprise Group was successfully listed on the New York Stock Exchange
    Golden Meditech Co. Ltd. (Hereinafter referred to as "Golden Meditech" or "Group"; Hong Kong Stock Exchange stock code: 801) today announced that its subordinate department of cord blood hematopoietic stem cells ?CChinese Cord Blood Bank Enterprise Group (Hereinafter referred to "CCBC") has successfully realized spin-off and listed the New York Stock Exchange (Stock code: CO). At 9:30 on November 19, 2009, the United States Eastern Standard Time, CCBC stock was officially traded in the NYSE. (December 30, 2009)

  • Domestic hospitals successfully realized the first overseas live broadcast of surgical sites
    From November 7 to 8, 2009, domestic hospitals successfully realized the first overseas live broadcast of surgical sites via the internet, it included 19 operations and lasted for two days. (2009年12月30日)

  • China's first successful long-distance consultation for a severe influenza A H1N1patient
    Recently, the NO.1 Hospital of China Medical University initiated influenza A remote diagnostic system to diagnose a 33-year-old male patient with severe influenza A at Fuxin Central Hospital and advised corresponding recommendations for treatment. (December 29, 2009)

  • New appearance of "Tarsus Hope Midwest Medical Equipment Exhibition" -- Integration of medical resou
    October 2009, the National Medical Technology Market Association has formally agreed to host Midwest Medical Equipment Exhibition in China. (December 29, 2009)

  • Philips Medical Imaging Base settled in Suzhou, China
    November 17, 2009, Royal Philips Electronics announced the establishment of Philips Medical Imaging Chinese base and held a signing ceremony with Suzhou Municipal Government. The base locates at the Suzhou Industrial Park and its total area is 62,000 square meters; its accumulative investment will reach 54 million U.S. dollars within future five years and more than 500 employees will be employed. The project is expected to be completed in mid-2012. (December 28, 2009)

  • Non-invasive continuous blood pressure monitor will be unveiled
    At the recently held " 2009 Eleventh China International Hi-Tech Fair", a company from Zhuhai City, Guangdong Province successfully demonstrated a "continuous, real-time, non-invasive WristAP blood pressure monitor", which made a contribution for resolving worldwide problem that non-invasive continuous blood pressure monitoring in the field of medical surveillance. (December 25, 2009)

  • Landwind cooperated with Kaitai to build a strong brand of respiration anesthesia industry
    October 29, Shenzhen Landwind Industry Co., Ltd. and Jiangsu Kaitai Medical Equipment Co., Ltd held a press conference in Chengdu. They officially announced a strategic alliance has been made between the two medical device companies, which mean that, following a breakthrough in medical imaging, Landwind took a further step toward the provider for operating room total solution and entered into the field of respiration anesthesia at one stroke. (December 25, 2009)

  • China's first Industry Base of Medical Device Science Technology was formally initiated at Chongqing
    Recently, China's first Industry Base of Medical Device Science Technology was formally initiated at Chongqing. It is expected that, in the next three years, annual output value of medical device industries in Chongqing will exceed 10 billion yuan. (December 23, 2009)

  • China's first digital X-ray machine production line settled in Ningjin, Xingtai, Hebei Province
    Recently, China's first digital X-ray machine production line was put into trial production at Tsinghua Tiandi Science and Technology Development Co., Ltd., Xingtai, Hebei Province. (December 22, 2009)

  • Global market outlook for blood processing supplies and equipment
    Research and Markets has announced the addition of the "Blood Processing Supplies and Equipment - A World Report" report to their offering. (December 21, 2009)

  • Color Doppler ultrasound S8 was awarded the "Quality Leadership Award"
    In November 2009, world-renowned consulting company Frost & Sullivan announced that S8 portable color Doppler ultrasound produced by Kaili company was awarded "2009 European Product Quality Leadership Award" (Product Quality Leadership Award). It is China's first medical device that won the honor in the quality of medical products, which is another affirmative evaluation for the performance and quality of ultrasound products of Kaili Co,Ltd. (December 21, 2009)

  • Beijing Friendship Hospital Introduced City's First PT Functional Digital Mammography Machine
    Early in October this year, Affiliated Beijing Friendship Hospital of Capital University of Medical Sciences began to use newly introduced Beijing's first PT functional digital mammography machine to provide more scientific and accurate examinations for patients, up to November 9, 2009, 209 patients have been tested. (December 21, 2009)

  • GE Healthcare released the world's first gemstone energy spectrum CT
    On November 15, GE Healthcare released it¡¯s the newest CT product ¡°gemstone energy spectrum CT¡± in Beijing. As the world's first gemstone energy spectrum CT, both high-resolution imaging and ultra-low radiation dose of it has achieved revolutionary breakthroughs. (December 21, 2009)

  • Trends in the global DNA probes-based diagnostics market
    Research and Markets has announced the addition of the "DNA Probes-Based Diagnostics - A Worldwide Market Review" report to their offering. (December 10, 2009)

  • Canadian panel promotes new reactor
    The Canadian government should build a new nuclear reactor to produce medical isotopes and guarantee an adequate supply for the country, an expert panel has recommended. (December 10, 2009)

  • Taiwan Spirit launched "LCD Electronic Blood Pressure Monitor"
    Recently, Taiwan Spirit launched it's the latest product "LCD electronic blood pressure monitor" with a mercury-free LCD screen; the device has high mobility and fully integrates the traditional style and the most advanced technologies. (December 09, 2009)

  • China's IV solution market capacity will reach 8.5 billion bottles/bags in 2011
    The preface of recently completed " China 2009-2013 Infusion Market Forecast and Investment Prospect Report" pointed out that, in 2007, China's sales of IV solution was 6.4 billion bottles/bags; in 2008, it reached 7.0 billion bottles/bags which increased by 9.4%. (December 09, 2009)

  • Anke launched China's first intraoperative CT machine
    At the recent 2009 CMEF conference in Chengdu, Anke strongly launched China's first intraoperative CT machine-integrative intelligent surgical system is the first perfect combination and comprehensive solution for CT images and systemic intraoperative surgical navigation technique. (December 09, 2009)

  • BrainPort for the visually impaired: 'seeing' with the tongue
    According to the National Institutes of Health, more than one million Americans over the age of 40 are legally blind - defined by U.S. law as vision that is 20/200 or worse, or have a field of view that is less than 20 degrees in diameter. (November 25, 2009)

  • iPhone Wheelchair App Puts Users in Control
    There are iPhone-controlled cars and beds, now one company plans to integrate iPhones/iPods in its wheelchairs for a new kind of accessibility. (November 25, 2009)

  • New Market Research Report on Blood Flow Measurement Devices
    Research and Markets has announced the addition of the "Blood Flow Measurement Devices - Global Market Opportunities" report to their offering. (November 25, 2009)

  • MicroPort Successfully Developed Cardiac Radiofrequency Ablation Catheter FireMagic
    Recently, cardiac radiofrequency ablation catheter FireMagic developed independently by MicroPort Medical (Shanghai) Co., Ltd has been widely used in clinical treatment. (November 20, 2009)

  • China has Developed a New-type Anti-bacterial and Anti-flu far Infrared Mask
    Recently, Tianjin Mingda Technology Development Co., Ltd. successfully developed a new-type far infrared mask with anti-bacterial and anti-flu functions. (November 20, 2009)

  • Annual Yield of CT Machine of Siemens Healthcare (China) Reached 1,000 Sets
    Recently, a ceremony was held in Siemens Healthcare (China) to celebrate its annual yield of CT machine reached 1,000 sets. All these CT machines were produced and assembled in Shanghai and it was supplied for Chinese and global markets. (November 20, 2009)

  • Key Trends Driving The Dynamism in The Japanese Interventional Cardiology Devices Market
    Research and Markets has announced the addition of GlobalData's new report "Japan Interventional Cardiology Devices: Coronary Stents to Drive Growth" to their offering. (November 11, 2009)

  • Two B Ultrasonic Examination Techniques Originated by Wenzhou Medical College
    at the 12th Conference of World Ultrasound Congress recently held in Australia, Prof. Huang Pingtong, the director of Ultrasound Division of the Second Affiliated Hospital of Wenzhou Medical College, reported two advanced diagnostic techniques namely B-ultrasound-double angiography technique for the determination of state of gastric cancer (November 11, 2009)

  • Shenzhen Medical Device Test Center can Provide English Test Report
    Recently, it is understood from Shenzhen Food and Drug Administration that Shenzhen medical device test can provide accurate test reports for those medical devices "Made in Shenzhen " ; in addition, they can also provide English test reports which can meet international standards and are recognized each other by various international inspection and testing organizations, (November 03, 2009)

  • China Has Become Asia-Pacific Region's Second-Largest Drug-Eluting Stent Market
    It is understood from recent 20th Great Wall International Conference of Cardiology and the 15th International Conference of Cardiovascular Drug Therapy which are hold in 2009 that patients with coronary heart disease in China increased year by year; moreover, the annual growth rate of total of stent implantation surgery has been more than 20%. (November 03, 2009)

  • New Medical Devices Designed For Laparo-Endoscopic Single-Site Surgery Introduced By Olympus
    Olympus, has introduced three new surgical instruments specifically designed for Laparo-Endoscopic Single-Site (LESS) surgery. LESS surgery is an advanced, minimally invasive surgical technique in which an endoscope and hand instruments are inserted through an access port via a single incision often made in the navel. (October 21, 2009)

  • Detecting the Undetectable in Prostate Cancer Screening
    A team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy. (October 21, 2009)

  • First Human Implants of the Conformable GORE TAG Thoracic Endoprosthesis Performed
    W. L. Gore & Associates (Gore) recently announced the first human implants of the next generation Conformable GORE TAG® Thoracic Endoprosthesis: for the treatment of thoracic aortic aneurysms (TAAs). The first implants were performed by Joshua Rovin, MD and Eugene Murphy, MD, at Bayfront Medical Center and William McMillan, MD and Scott Schultz, MD, at North Memorial Medical Center. (October 21, 2009)

  • Medtronic's Resolute Stent Maintains Strong, Sustained Efficacy and Safety in Long-Term Follow-Up
    Three-Year Results of RESOLUTE Trial Include No New Target Lesion Revascularizations and No Instances of Stent Thrombosis New clinical data released today at a major meeting of interventional cardiologists show strong and sustained efficacy and safety of the Resolute® Zotarolimus-Eluting Coronary Stent from Medtronic, Inc. (NYSE: MDT) in long-term patient follow-up. (October 13, 2009)

  • Automotive Technology Could Lead to New High Tech Diagnostic Tool
    Research at the University of Warwick have taken high tech gas sensors normally used to test components for premium cars and applied the same techniques to human blood, human urine, and even cow dung samples from local cow pats. The results could lead to a new high tech medical tool that could provide a fast diagnosis for some of the most difficult gastrointestinal illnesses and metabolic diseases. (October 13, 2009)

  • Cook Medical Established Its Product Transportation Center in Shanghai
    Recently, medical device company Cook Medical established its Asia-Pacific Product Transportation Center in Shanghai; at the same time, the company announced a new office will be founded in Taipei. (October 13, 2009)

  • China's Syringe Export Increased by 25% in the First Half Year
    Impacted by some advantageous factors such as the continuous increase of global medical device market and the increased demands for Chinese medical device products, China's syringe export increased greatly in the first half year and the total sum broke through 125 million, which increased by 25% comparing with the same period of last year; moreover, the export price also raised by 6.83% comparing with the same period of last year. (October 13, 2009)

  • Chongqing Medical Device Industry Technology Innovation Strategic Alliance Came into Existence
    Chongqing Medical Device Industry Technology Innovation Strategic Alliance was established formally on Sep. 10. 10 enterprises including Chongqing Haifu (HIFU) Technology Co., Ltd., were chosen to be the first group of core enterprise. (September 24, 2009)

  • GE Launches New Venue 40 Miniaturized Ultrasound Product Line
    GE Healthcare, yesterday introduced the new Venue™ ultrasound product line to the medical market. The Venue 40, the first product launched, provides visualization for needle guidance procedures and rapid diagnostics in real-time at the bedside. These "point of care" settings are the fastest growing in ultrasound around the world. (September 24, 2009)

  • Taiwan's Industries Should Pay Attention to Market Access Conditions Before Entering into Mainland
    He Xuewen, head of ¡°Shenzhen medical equipment and health care enterprises delegation¡±, pointed out it at Taiwan that Taiwan's related medical device enterprises must pay their attentions to market standards and access conditions before they finally entered into Chinese mainland markets. (September 24, 2009)

  • Cyntellect Unveils New Celigo Cytometer
    Cyntellect, Inc., unveiled its Celigo™ adherent cell cytometry system, the Company¡¯s new platform for non-invasive in situ live cell imaging. The Celigo Cytometer provides unsurpassed speed, flexibility and precision of cellular analysis across a wide range of applications, including cell health assays, cell culture maintenance, toxicity assays and assays for detecting the highest antibody-secreting cells within a population. (September 22, 2009)

  • Cook Medical Launches the CE Marked Zilver PTX Drug-Eluting Peripheral Stent for Treating PAD
    In a breakthrough development that could dramatically reduce the number of leg amputations and painful bypass graft surgeries performed annually on European patients, a first-of-its kind drug-eluting stent for a widespread form of peripheral arterial disease (PAD) is now available to physicians throughout the European Union. (September 22, 2009)

  • Invatec Launched a 3D Distal Embolic Protection System for Carotid Artery Stenting
    Invatec, a comprehensive innovator of interventional products, today introduced FiberNet®, a 3-dimensional distal Embolic Protection System (EPS) for Carotid Artery Stenting with the lowest crossing profile (0.031¡¯¡¯) and highest performance capabilities on the market, manufactured by Lumen Biomedical. FiberNet provides superior deliverability and can be used in vessels ranging from 3.5 to 7 mm. (September 21, 2009)

  • FDA Clears Hansen Medical's Sensei X Robotic Catheter System
    Furthering the medical robotic frontier in electrophysiology (EP), Hansen Medical, Inc. (NASDAQ: HNSN) yesterday announced it has received U.S. Food & Drug Administration (FDA) clearance for its next generation Sensei® X Robotic Catheter System and it introduced the Artisan Extend™ Control Catheter. The company also introduced the Lynx™ Robotic Ablation Catheter, a small, flexible irrigated ablation catheter for customers in Europe. (September 17, 2009)

  • Abbott to bring Xience V to China
    Abbott Laboratories has received Chinese State Food and Drug Administration (SFDA) clearance for its Xience V everolimus-eluting coronary stent system. (September 16, 2009)

  • Implantable Defibrillator Therapy not Beneficial For Women with Heart Failure
    Implantable cardioverter-defibrillators do not appear to be associated with a reduced risk of death in women with advanced heart failure, according to a meta-analysis of previously published research in the September 14 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. (September 16, 2009)

  • China Emergency Medical Equipment Approval Obtains its "Green Light"
    September 2, the State Food and Drug Administration issued a "notice on the issuance of emergency medical device approval process" which provides a "green light" for the approval of medical equipment required by public health emergencies. According to the requirements of the "notice", all the technical reviews and administrative approvals of confirmed first-class of medical equipment will be completed within five working days. (September 14, 2009)

  • International Center for Argon-Helium Cryotherapy Established in Tianjin Cancer Hospital
    August 10, the founding ceremony of Tianjin's first international cancer treatment center for argon-helium refrigeration was held in Tianjin Cancer Hospital. At that time, Hao Xishan, academician of Chinese Academy of Engineering, chairman of Chinese Anti-Cancer Association and the president of Tianjin Cancer Hospital and Prof. Frank who is the president of the International Society of Cryosurgery attended the ceremony. (September 14, 2009)

  • Mindray HyBase 6100 Type Operating Table Won the iF Industrial Design Award
    Recently, HyBase 6100-type operating table developed by Nanjing Mindray Medical Company, the most standout medical product among hundreds of exhibits from many well-known companies, won the "iF industrial design award" again for its advantages of compact design, superb technology and excellent performance etc. (iF Design Award China 2009) (September 14, 2009)

  • Report on Global Biomaterial Market Released
    Research and Markets (http://www.researchandmarkets.com/research/2ee21b/global_biomaterial) has announced the addition of the "Global Biomaterial Market (2009-2014)" report to their offering. (September 14, 2009)

  • TeraMedica Awarded Key Medical Imaging Patent
    TeraMedica Healthcare Technology was granted a patent by the United States Patent and Trademark Office for their Evercore® solution. According to Jim Prekop, TeraMedica's President and CEO, the patent will differentiate and protect their position in the global marketplace. TeraMedica is a Milwaukee-based medical informatics company in the area of patient-centric, large-scale clinical content management for healthcare. (September 10, 2009)

  • Wandong Medical Planned to Invest Eight Million Yuan to Establish its Software Subsidiary
    August 18, Wandong Medical announced that the company will invest eight million yuan to establish a wholly-owned software subsidiary. (September 10, 2009)

  • Neusoft Launched its Three New Flagship Medical Products
    August 28, a strategy and new product launches conference aimed at the theme ¡®innovation, challenge and beyond itself¡¯ was held by Neusoft Medical. The medical company officially launched its three new flagship medical products on the conference (September 10, 2009)

  • China's First Top-Level Health Checkup 4S Center Was Founded in Beijing
    Recently, the official ground-breaking of Ciming building which locates at the heart of Olympic Zone of Datun of Chaoyang District of Beijing initiated and it indicated the project-world-class level health maintenance club officially launched in Beijing. (September 10, 2009)

  • New Procedure for Transapical Valve Replacement Minimizes Trauma and Blood Loss
    Edwards Lifesciences Corporation (NYSE: EW), the world leader in the science of heart valves, announced today the first successful clinical use of its new lower-profile Ascendra 2 transapical delivery system, designed to benefit both patients and physicians by minimizing trauma and blood loss, and facilitating transcatheter heart valve delivery and deployment. (September 09, 2009)

  • Shanghai Jiaotong University is Challenging the Limits of in vivo Micro-vascular Imaging
    Recently, a synchrotron radiation X-ray medical imaging research team which is led by Prof. Xuxueming who is from Med-X Research Institute of Shanghai Jiaotong University planned to build an internationally advanced synchrotron radiation medical imaging research centre. The main target of the centre is to develop innovative synchrotron radiation imaging methods which will challenge the limits of in vivo micro-vascular imaging. (September 09, 2009)

  • FDA Approves the Distribution of IMRISNV and IMRIScardio Systems
    IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") today announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA), permitting the Company to market its newest products, IMRISNV and IMRIScardio in the United States. (September 09, 2009)

  • Medical Devices Summit 2009
    Key drivers behind the Asian Medical Devices industry are the large population and accelerated ageing population. Yet, reducing cost per unit is an important element for healthcare providers and hence countries in Asia Pacific are moving towards cost-effective medical devices developed by domestic companies. As such, there is tough competition for domestic companies in China, not only with MNCs but also amongst themselves to gain a share of the market. (September 08, 2009)

  • Medtronic's Paradigm Veo Wireless Insulin Pump Helps Prevent Hypoglycemia
    At this year¡¯s annual meeting of the International Society for Pediatric and Adolescent Diabetes (ISPAD) in Ljubljana, Slovenia, Medtronic announced the global launch of a novel technology designed to provide additional protection against the risks associated with hypoglycemia. (September 03, 2009)

  • New Molecular Sensor Could Identify Zinc-Related Diseases
    Scientists have developed a new molecular sensor that can reveal the amount of zinc in cells, which could tell us more about a number of diseases, including type 2 diabetes. The research, published on August 30th in Nature Methods, opens the door to the hidden world of zinc biology by giving scientists an accurate way of measuring the concentration of zinc and its location in cells for the first time. (September 02, 2009)

  • Fibroscan, A Painless Alternative to Liver Biopsy for Evaluating the Stage of Liver Fibrosis
    ¡°Furui Liver Fibrosis Forum¡± was held in Beijing on July 24th. The conference issued multi-center clinical validation results of non-invasive detection equipment (FibroScan) for Chinese hepatitis B patients. (September 01, 2009)

  • Varian Debuts Unique: World's First Low-Energy Radiotherapy System
    Varian Medical Systems (NYSE: VAR) is introducing the world's first low-energy radiotherapy system with image-guidance and RapidArc treatment capabilities for international cancer clinics. Varian's UNIQUE(TM) radiotherapy system is expected to make advanced care more affordable and more widely available to cancer patients around the world. (September 01, 2009)

  • FDA Approves Zoll Medical's Wearable Dfibrillator
    Zoll Medical Corp. said Tuesday it received Food and Drug Administration marketing approval for a new model of its LifeVest wearable defibrillator. (August 27, 2009)

  • China Proposed to Establish Standardized Electronic Medical Records
    Recently, China's Ministry of Health issued request for Comments on ¡°Basic Structure of Electronic Medical Record and Data Standard (Comments Draft)¡± on its website so as to further carry out relevant medical system reformations. (August 27, 2009)

  • FDA Proposes Mandatory Electronic Safety Reporting
    New Rules will Help Strengthen Postmarket Safety Data Collection The U.S. Food and Drug Administration is proposing to amend postmarket safety reporting regulations for three of its centers to require that manufacturers and other facilities subject to current reporting requirements submit their reports in an electronic format. (August 27, 2009)

  • China has Successfully Developed Capsule-Type Medical Micro-Robot
    Recently, a research team led by Prof Zhangyongshun who is from Dalian University of Technology has been studying capsule-type medical micro-robot. The vertical movement of the robot in the intestine has been realized and the outcome has been published in the Science in China Series E: Technological Science (No.7, 2009). (August 25, 2009)

  • Zein can be Used as the Material of Medical Polymer Stent
    zein three-dimensional porous biomimetic stent material is a new-type natural stent material which is made of main storage protein in the corn. With good biocompatibility, biodegradability and mechanical properties which are better than that of all other natural polymer stents, the development and the application of it are very promising in the near future. (August 25, 2009)

  • Marketstrat Releases Report on Ultrasound Systems Worldwide
    The world Medical Ultrasound equipment, accessories, and maintenance services market is expected to reach $4.7 billion by 2012. Higher growth rates towards the end of this period are projected as economic conditions stabilize around the world leading to sizeable increases in healthcare expenditures, particularly in high-end capital equipment acquisition. (August 25, 2009)

  • China's First Heavy-ion Cancer Treatment Center has been Set up in Lanzhou
    Recently, the signing ceremony of ¡®Lanzhou Heavy Ion Cancer Center¡¯ was held in Lanzhou. which indicates that China¡¯s first heavy-ion cancer treatment center has been set up formally in Lanzhou. It makes China become the fourth country that can carry out clinical trials and researches on heavy-ion cancer treatment as well as develop formally large-scale heavy-ion cancer treatment in the world. (August 18, 2009)

  • Neusoft Medical's 16-slice Spiral CT Scanner has been Approved by FDA and Exported to the U.S.
    On July 16, Neusoft Medical Systems Co., Ltd. (Neusoft Medical) officially announced that its new flagship product in 2009-NeuViz 16-slice multi-slice spiral CT scanner has been successfully developed and approved by FDA (U.S. Food and Drug Administration). Recently, the first 16 multi-slice CT scanner has been shipped to their U.S.-based customers officially. (August 18, 2009)

  • A Variety of Ant Medical Products have Obtained CE and FDA Certifications
    A few days ago, a good news came from Shenzhen Ant Hi-Tech Industrial Co., Ltd. (http://www.antmed.com/ejj.htm£©that a series of products produced by the company have obtained CE certification, (August 17, 2009)

  • FDA Issues Public Health Notification On Glucose Monitoring Technology
    Recently, The U.S. Food and Drug Administration (FDA) advised health care practitioners and patients against using certain glucose monitoring technology that employs a specific test strip when the patients are also receiving therapeutic products containing non-glucose sugars. (August 17, 2009)

  • Xiangya Hospital Successfully Carried out a Gallstone Surgery with Metal Multi-cavity Cholecystoscop
    Recently, Xiangya Hospital of Hunan Central South University successfully carried out a case of gallstone surgery first on a 37-year-old patient with metal multi-cavity cholecystoscope rather than cholecystectomy, this new minimally invasive surgery is independently developed by the hospital and the patient surnamed Liu has recovered and discharged from hospital. (August 14, 2009)

  • 2009 China International Emergency Medical Expo will be Held in Chengdu
    2009 China International Emergency Medical Expo (CEME) will be held on October 28-31 at the Chengdu Century City New International Convention & Exhibition Center. CEME is the grandest meeting in the field of emergency medicine and disaster assistance in China and the products exhibited by it involve all products in these fields. (August 10, 2009)

  • Esophageal Stent with Radioactive Particles can Treat Medium-term or Advanced Esophageal Cancer
    Recently, a clinical application and promotion class on esophageal stent with radioactive particles has been held by West China Hospital of Sichuan University and about more than 100 physicians who are from Sichuan and Chongqing and work at the different departments such as invasive technology department, digestive surgery, department of oncology, department of nuclear medicine and department of radiotherapy etc have attended this promotion class for special technology. (August 10, 2009)

  • FDA Steps Up Efforts To Prevent Non-compliant Investigators And Others From Participating In New Pro
    Recently,the U.S. Food and Drug Administration announced it has stepped up its efforts to prevent non-compliant investigators and others from participating in new product development. The FDA's procedures for debarment and disqualification have been enhanced to better protect participants in clinical studies and for ensuring the safety and effectiveness of the medical products marketed to the American public. (August 10, 2009)

  • A New-type Polyester Urinary Tract Stent has been Developed by Tsinghua University
    By means of a five-year close cooperation between a study group of Department of Materials of Tsinghua University led by Prof. Cuifuzhai and several medical experts from the Department of Urology of the Second Hospital of Hebei Medical University, (August 06, 2009)

  • First-aid Hemostatic Dressing has Filled up the Gap in the Field of Traumatic First-aid Hemostasia
    First-aid hemostatic dressing with original intellectual property rights developed by Worldwide Biotech & Pharmaceutical Company has overcome the international bottleneck problem on the hemostasia of artery injuries which are caused by serious field trauma, and thus create favorable conditions for human¡¯s first aid. (August 06, 2009)

  • China will Invest 100 Billion yuan to Build Primary Medical Institutions
    Recently, Zhao Zilin, the minister of Department of Planning and Finance of Ministry of Health, introduced on a ministry of health medical devices centralized procurement information conference that, up to 2011, China will invest about 100 billion yuan to build primary medical institutions such as county-level hospitals, centeral village clinic and community health service center etc. (August 06, 2009)

  • China's Successful Development of Hemoperfusion Device for Drug Addiction Rehabilitation
    A few days ago, a disposable hemoperfusion device, dedicated to remove the morphine in the drug addicts' body, has been developed first in China; it is a unique medical device for drug addiction rehabilitation in the world and it has opened up an entirely new way for drug addiction treatment. (July 28, 2009)

  • The Establishment of China's Sterile Medical Device Automation Equipment Manufacturing Industrial Base in Yuhuan, Zhejiang
    June 22, China's unique sterile medical device automation equipment manufacturing industrial base was established in Yuhuan, Zhejiang. (July 28, 2009)

  • China's Successful Development of the First Excimer Laser Therapeutic Apparatus with Independent Intellectual Property Rights
    Recently, China's first excimer laser therapeutic apparatus with independent intellectual property rights has been developed by Zhejiang WenyiLaserSight Medical Laser Technology Co., Ltd, which broke the technical monopoly derived from the Western countries. (July 28, 2009)

  • The Implementation of "the Household Registration System" for High-risk Medical Devices in Zhejiang
    Recently, in order to strengthen the supervision of medical devices and ensure safe uses for people, the Food and Drug Administration of Jiaojiang District, Taizhou City, Zhejiang Province carried out ¡®the household registration system¡¯ for high-risk medical devices such as medical apparatus and equipments, implantable and interventional medical devices, diagnostic reagents etc. (July 28, 2009)

  • Study Proved that Eating More Fresh Fruits and Vegetables could Reduce the Radiation
    Recently, a joint study carried out by Harbin Medical University and Jilin University proved first that fruits such as apple contain abundant quercetin which had a certain degree of protective effect on ionizing radiation injury (July 28, 2009)

  • The Promoted Standardization of Medical Devices in Guangdong
    Guangdong Medical Devices Quality Supervision and Inspection Institute, In the light of the requirements of State Food and Drug Administration and Guangdong Medical Devices Supervision Work Conference, organized seminar led by related experts to examine and approve industry standards (July 28, 2009)

  • China's First Self-developed Cardiovascular Balloon Dilatation Catheter has been Put into Production
    Recently, PTCA (balloon dilatation catheter) has been successfully developed by China's first high-tech bio-medical enterprise-Dongguan Dikai Precision Tube Company and it has been formally put into production to domestic and foreign markets. (July 28, 2009)

  • Polysulfone Membrane Dialyzer has been Put on the Market by Shandong Weigao Group Medical Polymer Co
    At present, Weigao polysulfone membrane--China¡¯s unique independently developed brand of blood dialyzer has been put on the market. (July 28, 2009)

  • PET has been Successfully Developed by Neusoft Corporation and It has been Approved by U.S.FDA
    A few days ago, Neusoft Corporation officially announced that the independently developed PET (Positron Emission Tomography) has been successfully developed by its wholly-owned subsidiary-Neusoft Medical System Co., Ltd. in Shenyang, China. (July 28, 2009)

  • Anti-viral Mask has been Developed Successfully by CAS
    A few days ago, a kind of anti-viral mask which can kill viruses and bacteria instantaneously was developed successfully by the project team which was consisted of Technical Institute of Physics and Chemistry of CAS and National Health Industry Management Association Antimicrobial Industry Branch (Hereinafter referred to as 'anti-bacterial association'). (July 27, 2009)
Disclaimer   |   Terms of Use   |   About Us   |   Contact Us
Copyright ©2010 Tech-ex Dot Com Ltd. All rights reserved.